Earnings Troubles May Signal Larger Issues for Hangzhou Zhongtai Cryogenic Technology (SZSE:300435) Shareholders
Earnings Troubles May Signal Larger Issues for Hangzhou Zhongtai Cryogenic Technology (SZSE:300435) Shareholders
Hangzhou Zhongtai Cryogenic Technology Corporation's (SZSE:300435) recent weak earnings report didn't cause a big stock movement. However, we believe that investors should be aware of some underlying factors which may be of concern.
中泰股份(SZSE:300435)最近的业绩报告弱势,并未引起股票大幅波动。然而,我们认为投资者应该注意一些潜在的担忧因素。
How Do Unusual Items Influence Profit?
非常规项目如何影响利润?
Importantly, our data indicates that Hangzhou Zhongtai Cryogenic Technology's profit received a boost of CN¥29m in unusual items, over the last year. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. And, after all, that's exactly what the accounting terminology implies. If Hangzhou Zhongtai Cryogenic Technology doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.
重要的是,我们的数据显示,中泰股份的利润在过去一年中因飞凡项目获得了2900万人民币的提振。我们不能否认,更高的利润通常让我们感到乐观,但我们更希望利润能够持续下去。当我们分析了成千上万家上市公司的数据后,我们发现一年中由飞凡项目带来的提振往往不会在下一年重复。毕竟,这正是会计术语所暗示的。如果中泰股份未看到该贡献在下一年重复,那么其他条件相同,我们预计其利润将在当前年度下降。
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
这可能会让您想知道分析师对未来盈利能力的预测。幸运的是,您可以单击此处查看基于其估计的未来盈利能力的互动图表。
Our Take On Hangzhou Zhongtai Cryogenic Technology's Profit Performance
我们对中泰股份的利润表现的看法
We'd posit that Hangzhou Zhongtai Cryogenic Technology's statutory earnings aren't a clean read on ongoing productivity, due to the large unusual item. Therefore, it seems possible to us that Hangzhou Zhongtai Cryogenic Technology's true underlying earnings power is actually less than its statutory profit. Nonetheless, it's still worth noting that its earnings per share have grown at 23% over the last three years. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. Case in point: We've spotted 1 warning sign for Hangzhou Zhongtai Cryogenic Technology you should be aware of.
我们认为中泰股份的法定盈利并不能清晰反映持续生产力,因为有大笔飞凡项目。因此,据我们看来,中泰股份的真正基础盈利能力实际上可能低于其法定利润。尽管如此,仍值得注意的是,其每股收益在过去三年中增长了23%。当然,在分析其盈利方面我们仅仅是粗略了解了一部分;人们也可以考虑边际、预测增长和投资回报率等其他因素。考虑到这一点,除非我们对风险有深入了解,否则我们不会考虑投资股票。案例证明:我们发现了中泰股份的1个警示信号,您应该注意。
This note has only looked at a single factor that sheds light on the nature of Hangzhou Zhongtai Cryogenic Technology's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
这篇笔记只研究了一个能揭示中泰股份利润性质的因素。但有许多其他方法可以了解一家公司。例如,许多人认为高股本回报率是有利的商业经济指标,而另一些人喜欢“跟随资金”并寻找内部人员买入的股票。因此,您可能希望查看这批自豪具有高股本回报率的公司,或者这份具有高内部所有权股票的列表。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。